O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+38.81%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+44%)
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
11.42%
Top 10 Holdings %
Top 10 Hldgs %
37.61%
Holding
165
New
23
Increased
27
Reduced
20
Closed
17
Top Buys
| 1 |
ARS Pharmaceuticals
SPRY
|
$405M |
| 2 |
AbCellera Biologics
ABCL
|
$338M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$153M |
| 4 |
UnitedHealth
UNH
|
$137M |
| 5 |
Pfizer
PFE
|
$133M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$315M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$67.6M |
| 3 |
Ascendis Pharma
ASND
|
$66.4M |
| 4 |
Exelixis
EXEL
|
$58.8M |
| 5 |
Eledon Pharmaceuticals
ELDN
|
$46.7M |
Sector Composition
| 1 | Healthcare | 98.28% |
| 2 | Financials | 0.52% |
| 3 | Technology | 0.51% |
